Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise of future Omnipod innovation to address unmet needs, improve ...
A doctor-tech leader from India argues that genomic data infrastructure, resistance forecasting and sovereign AI discovery tools will be critical to future regional pandemic response.
Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
Imagine a problem so fiendishly hard that one of the greatest mathematicians of the 20th century publicly mused that even alien civilisations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results